Skip to main content Skip to search Skip to main navigation

GDP inspections: How to avoid defects

7 min. reading time | by Lea Joos and Doris Borchert
Published in LOGFILE 02/2020

Interview with Lea Joos, GMP inspector and author of the new GMP Compliance Adviser Chapter 16.S.2 "GDP inspections: frequent deficiencies in the qualification of logistics service providers and how to avoid them"

Mrs. Joos, you put in your new chapter "GDP inspections: Frequent deficiencies and how to avoid them" the 10 most common deficiencies in the qualification of logistics service providers. In your opinion, where are the biggest deficits?

Very often the quality risk management for the qualification of logistics service providers is too immature. This can have serious consequences: If a logistics service provider is not sufficiently qualified and shortcomings in the logistics service provider are overlooked during the qualification process, this can later lead to situations that call drug quality and safety into question.

Why is risk management not used correctly in GDP practice?

It is often because unsuitable methods are used, or because assumptions are made rather than facts. The following example: At the beginning of the cooperation with a logistics service provider, it is not yet possible to rely on experience or even data. Therefore, an FMEA in which appearance and detection probabilities are evaluated with numbers makes little sense. Other methods, such as fault tree analysis, are more suitable at this point. Nevertheless, we often see FMEAs in which the risks were underestimated, so that these risks were not pursued further in the qualification process.

Are there further deficiencies that can frequently be found in the GDP area that you would like to address here?

Yes, there is indeed a topic, which provides again and again for long faces with the inspected company: the so-called "GDP certificates". If such a certificate is available, the scope of the qualification is gladly reduced. One feels safe because the GDP conformity of the logistics service provider has already been proven.

What exactly is the problem with these certificates?

Beside the GDP certificates of the supervisory authority there are also GDP certificates that are issued by private providers. The criteria, after which a GDP conformity is confirmed by a private certifier, are however not generally known and unfortunately also not uniformly fixed. Therefore one cannot simply trust these certificates blindly.

When are GDP certificates of private providers recognised during an inspection?

In order for a reduced scope of qualification to be recognised on the basis of a GDP certificate, two requirements must be met: On the one hand, the set of rules, the test criteria and the suitability and competence of the certifier must be known. It is therefore a question of transparency and traceability. On the other hand, the extent of the reduction must be risk-based and based on an assessment of the rules and regulations and the certifier. That brings us back to the subject of risk management.

Ms. Joos, thank you very much for this interesting insight into your work!

The interview was conducted by Doris Borchert, PhD, editor at GMP Publishing Peither.


Reading sample

Read below an excerpt from the new GMP Compliance Adviser Chapter 16.S.2 "Frequent deficiencies in the qualification of logistics service providers and how to avoid them".

In this chapter, GMP/GDP inspector Lea Joos describes the most common deficiencies in the qualification of logistics service providers and points out strategies for avoiding them. For each defect, you receive clear instructions in the form of a checklist.

Insufficient transparency

The deficiency

During the inspection, it was not clear why the requalification of logistics service provider Y was delayed. The initial qualification was carried out in 2014. According to the SOP, a requalification should have taken place in 2017. However, the audit did not take place until 10 October 2018. A notification of deviation was not created. There was no audit plan in place. (Ref: EU GDP Guidelines, 1.3, 4.1, 4.2 and 7.2)

The problem was

Good documentation should permit the tracking of operations relevant to GDP at any time (EU GDP Guidelines, 4.1).

Why did transparency fail in this case?

The SOP contains a clear specification for requalification. In the case of logistics service provider Y, the specified interval of 3 years could not be adhered to. The associated documentation concerning the requalification of logistics service provider Y by the wholesale distributor contained no reasons for the delayed audit. A notification of deviation was not created even though the interval specified in the SOP was not adhered to.

A deviation from SOP specifications is not a deficiency in principle. However, the deviation must be documented. The wholesale distributor should have noticed the deviation, documented at first. The wholesale distributor must then make an effort to look into the cause. In this case, according to the information provided by the wholesale distributor, two additional audits for an initial qualification and a follow-up audit had to be carried out unexpectedly in 2017. The audit of logistics service provider Y was therefore postponed by the wholesale distributor until 2018. There was a lack of appropriate risk assessment and documentation.

How to avoid this error

To illustrate the adjustment of the audit sequence, a risk analysis and assessment is required. This does not require the immediate creation of an FMEA. Where applicable, less complex risk analysis tools can also be used. The next steps must then be adapted accordingly in the notification of deviation and, if applicable, in the audit plan.

An audit plan can give a clearer overview in such cases. It makes it easier to see

  • Which audits are to be conducted and when
  • Which audits have been conducted and when
  • Which additional audits were necessary and
  • Which audits could not be conducted and were therefore postponed
Contract acceptor Last audit Planned audit 2017 Audit conducted on
W Not applicable, initial audit Was not yet envisaged in planning 20.05.2017
X Not applicable, initial audit Was not yet envisaged in planning 05.06.2017
Y 05.07.2014 June 2017 Postponed until 2018 (see notification of deviation 123)
Z 10.01.2014 February 2017

04.04.2017

     

Follow-up audit required due to large number of serious deficiencies:

      15.08.2017

Figure 1 shows what a wholesale distributor’s audit plan for 2017 should have looked like in this case.

Your checklist for audit planning

Transparency of audit planning

Create an audit plan with the following information for each contract acceptor subject to auditing:

  • Interval for re-auditing
  • Date of last audit
  • Date of next planned audit
  • Date of implementation
  • Record deviations from the plan in the deviation system.
  • Make changes to the audit plan (postponements, additional audits) on a risk basis and document the decisions made in each case.

Figure 2 Transparency of audit planning


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Lea Joos
Lea Joos

You may also be interested in the following articles:

Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT